Related references
Note: Only part of the references are listed.Add-On Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex A Placebo-Controlled Randomized Clinical Trial
Elizabeth A. Thiele et al.
JAMA NEUROLOGY (2021)
A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects
Julie Crockett et al.
EPILEPSIA (2020)
Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome A Randomized Clinical Trial
Ian Miller et al.
JAMA NEUROLOGY (2020)
Cannabidiol efficacy and clobazam status: A systematic review and meta-analysis
Simona Lattanzi et al.
EPILEPSIA (2020)
Cannabidiol efficacy independent of clobazam: Meta-analysis of four randomized controlled trials
Orrin Devinsky et al.
ACTA NEUROLOGICA SCANDINAVICA (2020)
Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs
Philip N. Patsalos et al.
EPILEPSIA (2020)
Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study
Elizabeth Thiele et al.
EPILEPSIA (2019)
A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects
Gilmour Morrison et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A. Thiele et al.
LANCET (2018)
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Lesley Taylor et al.
CNS DRUGS (2018)
Evolution and course of early life developmental encephalopathic epilepsies: Focus on Lennox-Gastaut syndrome
Anne T. Berg et al.
EPILEPSIA (2018)
Time to onset of sustained ≥50% responder status in patients with focal (partial-onset) seizures in three phase III studies of adjunctive brivaracetam treatment
Pavel Klein et al.
EPILEPSIA (2017)
Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society
Cynthia Harden et al.
NEUROLOGY (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Expert Opinion on the Management of Lennox-Gastaut Syndrome: Treatment Algorithms and Practical Consideration
J. Helen Cross et al.
FRONTIERS IN NEUROLOGY (2017)
Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions
Adam P. Ostendorf et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2017)
Clobazam and clonazepam use in epilepsy: Results from a UK database incident user cohort study
Martin J. Brodie et al.
EPILEPSY RESEARCH (2016)
Thirty Years of Orphan Drug Legislation and the Development of Drugs to Treat Rare Seizure Conditions: A Cross Sectional Analysis
Jan Henje Doering et al.
PLOS ONE (2016)
Perampanel in the treatment of partial seizures: Time to onset and duration of most common adverse events from pooled Phase III and extension studies
David Ko et al.
EPILEPSY & BEHAVIOR (2015)
Definition and natural history of Lennox-Gastaut syndrome
Peter R. Camfield
EPILEPSIA (2011)
Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: A population-based study
Elaine C. Wirrell et al.
EPILEPSY RESEARCH (2011)
Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome
Y. T. Ng et al.
NEUROLOGY (2011)
Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study
Victor Biton et al.
EPILEPSY & BEHAVIOR (2010)
Clobazam in the treatment of Lennox-Gastaut syndrome
Joan A. Conry et al.
EPILEPSIA (2009)
Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology
Alexis Arzimanoglou et al.
LANCET NEUROLOGY (2009)
Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome
T. Glauser et al.
NEUROLOGY (2008)
Long-term prognosis for symptomatic (Secondarily) generalized epilepsies: A population-based study
Peter Camfield et al.
EPILEPSIA (2007)
Following catastrophic epilepsy patients from childhood to adulthood
TA Glauser
EPILEPSIA (2004)
Share Paper
